Literature DB >> 34297650

Microinvasive Glaucoma Surgery: An Evidence-Based Review.

Faith A Birnbaum1, Cameron Neeson1, David Solá-Del Valle1.   

Abstract

PURPOSE: Interest in micro-invasive glaucoma surgery (MIGS) has exploded over the last 8 years with an increase in MIGS procedures of at least 400% in the United States, according to Medicare data. MIGS is an umbrella term that can cover many different types of surgeries. This review focuses on peer-reviewed evidence for Trabectome®, iStent inject®, Kahook Dual Blade®, XEN® Gel Stent, and Hydrus®.
METHODS: We present key recent studies evaluating the efficacy and safety of MIGS in various types of glaucoma patients with different stages of disease.
CONCLUSION: We conclude that MIGS is generally safe and efficacious, although only some MIGS have been studied through randomized clinical trials. When comparing and contrasting the different MIGS procedures, large prospective studies are not yet the norm. High-quality large prospective studies involving MIGS will be an important next step as ophthalmologists decide how to incorporate MIGS into their surgical armamentarium.

Entities:  

Keywords:  Hydrus; Kahook Dual Blade; Micro-invasive glaucoma surgery (MIGS); Minimally invasive glaucoma surgery (MIGS); Xen Gel Stent; goniotomy; iStent; iStent inject

Year:  2021        PMID: 34297650     DOI: 10.1080/08820538.2021.1903513

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  3 in total

Review 1.  Corneal Endothelial Cell Loss in Patients After Minimally Invasive Glaucoma Surgery: Current Perspectives.

Authors:  Iwona Obuchowska; Joanna Konopińska
Journal:  Clin Ophthalmol       Date:  2022-05-25

2.  Comparison of surgical outcomes between initial trabeculectomy and Ex-PRESS in terms of achieving an intraocular pressure below 15 and 18 mmHg: a retrospective comparative study.

Authors:  Shunsuke Nakakura; Ryo Asaoka
Journal:  Eye Vis (Lond)       Date:  2022-03-01

3.  A Multi-Lumen Glaucoma Stent With Titratable Pressure-Lowering Effect: A Proof of Concept Study.

Authors:  Alexander Sverstad; Eirik Albert Torheim; Øystein Kalsnes Jørstad
Journal:  Transl Vis Sci Technol       Date:  2022-09-01       Impact factor: 3.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.